Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 Sep;101(9):e385-6.
doi: 10.3324/haematol.2016.147256. Epub 2016 May 31.

Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

Pier Luigi Zinzani  1 , Cinzia Pellegrini  2 , Lisa Argnani  2 , Alessandro Broccoli  2
Affiliations
Clinical Trial

Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

Pier Luigi Zinzani et al. Haematologica. 2016 Sep.
No abstract available

Keywords: diffuse large B-cell lymphoma; elderly; lenalidomide; relapsed; rituximab.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
6-year disease-free survival.
See this image and copyright information in PMC

References

    1. Mounier N, Gisselbrecht C. Relapses, treatments and new drugs. Best Pract Res Clin Haematol. 2012;25(1):49–60. - PubMed
    1. Friedberg JW. Relapsed/refractory diffuse large B-cell lymphoma. Hematology Am Soc Hematol Educ Program. 2011;2011:498–505. - PubMed
    1. Wiernick PH, Lossos IS, Tuscano JM, et al. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin’s lymphoma. J Clin Oncol. 2008;26(30):4952–4957. - PubMed
    1. Witzig TE, Vose JM, Zinzani PL, et al. An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma. Ann Oncol. 2011;22(7):1622–1627. - PubMed
    1. Zinzani PL, Pellegrini C, Gandolfi L, et al. Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. Clin Lymphoma Myeloma Leuk. 2011;11(6):462–466. - PubMed

MeSH terms

LinkOut - more resources